The Dark Side of Open-Access Journals | GenomeWeb

A growing number of open-access journals of questionable reputation are offering to publish "seemingly anything" for a fee and are preying on researchers to lend them credibility, The New York Times reports today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Open-Access Costs

Make a Note

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.